当前位置:首页 - 行情中心 - 祥生医疗(688358) - 财务分析 - 现金流量表

祥生医疗

(688358)

  

流通市值:29.85亿  总市值:29.89亿
流通股本:1.12亿   总股本:1.12亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金323,501,611.12214,096,928.9585,825,240.41434,507,555.85
  收到的税费返还30,388,388.2219,865,039.896,085,492.9927,853,696.1
  收到其他与经营活动有关的现金40,089,382.1331,924,504.8120,407,033.739,502,054.82
  经营活动现金流入小计393,979,381.47265,886,473.65112,317,767.1501,863,306.77
  购买商品、接受劳务支付的现金178,524,469.14113,916,999.9670,912,394.13205,231,590.34
  支付给职工以及为职工支付的现金95,871,999.1766,590,330.0936,710,268.64126,620,632.6
  支付的各项税费24,029,576.7420,776,407.138,380,729.7520,337,022.84
  支付其他与经营活动有关的现金43,263,876.3828,423,649.1813,220,124.5942,505,858.13
  经营活动现金流出小计341,689,921.43229,707,386.36129,223,517.11394,695,103.91
  经营活动产生的现金流量净额52,289,460.0436,179,087.29-16,905,750.01107,168,202.86
二、投资活动产生的现金流量:
  收回投资收到的现金678,660,400444,790,800200,590,7001,516,516,282.62
  取得投资收益收到的现金1,794,863.68366,397.26247,493.153,816,784.12
  处置固定资产、无形资产和其他长期资产收回的现金净额1,403,414.79495,920.68-5,570,480.92
  收到的其他与投资活动有关的现金2,707,868.483,236,912.831,230,853.145,686,788.22
  投资活动现金流入小计684,566,546.95448,890,030.77202,069,046.291,531,590,335.88
  购建固定资产、无形资产和其他长期资产支付的现金18,905,081.8212,164,652.064,969,935.4414,407,094.29
  投资支付的现金627,457,200490,457,20069,678,0001,459,359,882.62
  投资活动现金流出小计646,362,281.82502,621,852.0674,647,935.441,473,766,976.91
  投资活动产生的现金流量净额38,204,265.13-53,731,821.29127,421,110.8557,823,358.97
三、筹资活动产生的现金流量:
  吸收投资收到的现金---3,735,750
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---3,735,750
  分配股利、利润或偿付利息支付的现金53,203,921.4833,637,683.933,637,683.9111,874,753
  支付其他与筹资活动有关的现金1,942,981.451,165,235.34473,853.794,398,999.67
  筹资活动现金流出小计55,146,902.9334,802,919.2434,111,537.69116,273,752.67
  筹资活动产生的现金流量净额-55,146,902.93-34,802,919.24-34,111,537.69-112,538,002.67
四、汇率变动对现金及现金等价物的影响-28,772,343.89-22,018,896.19-12,966,786.29-30,544,053.35
五、现金及现金等价物净增加额6,574,478.35-74,374,549.4363,437,036.8621,909,505.81
  加:期初现金及现金等价物余额840,572,827.86840,572,827.86840,572,827.86818,663,322.05
  期末现金及现金等价物余额847,147,306.21766,198,278.43904,009,864.72840,572,827.86
补充资料:
  净利润-68,957,612.85-116,499,752.06
  资产减值准备-1,991,278.82-4,314,477.93
  固定资产和投资性房地产折旧-4,248,669.38-9,147,146.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,248,669.38-9,147,146.72
  无形资产摊销-423,162.76-1,373,825.57
  长期待摊费用摊销---893,119.15
  处置固定资产、无形资产和其他长期资产的损失--421,892.84--4,525,956.56
  公允价值变动损失--226,776.94--
  财务费用--192,597.67-11,446,093.17
  投资损失--345,657.79--3,429,755.01
  递延所得税-492,465.4--2,733,516.05
  其中:递延所得税资产减少-492,465.4--2,733,516.05
  存货的减少--18,659,042.64--7,029,025.22
  经营性应收项目的减少--20,169,855.62--35,678,578.26
  经营性应付项目的增加--4,622,439.81-12,051,360.47
  其他-1,054,017.89--56,186.2
  现金的期末余额-766,198,278.43-840,572,827.86
  减:现金的期初余额-840,572,827.86-818,663,322.05
  现金及现金等价物的净增加额--74,374,549.43-21,909,505.81
公告日期2026-10-282026-08-282026-04-282026-04-20
审计意见(境内)标准无保留意见
TOP↑